There’s limited knowledge about the potential value of marine growth on decommissioned offshore assets. CessCon Decom wanted to characterise the nutritional composition of the marine growth and assess the feasibility of extracting valuable components.

This project with NuCana and the University of St Andrews aimed to find a way to make cancer treatments safer and more efficient via a new technology to improve the bioanalysis of samples.

Lignin is a material obtained from woody biomass, such as forestry waste suitable for a range of applications. Sonichem wanted to investigate the feasibility of using their natural lignin in the production of advanced, bio-based and sustainable films and resins in packaging and composite manufacturing.

Successful project to assess the feasibility of extracting platform chemicals from spent lees delivers a valuable new feedstock, a bespoke analytical tool, additional product streams and evidence to substantiate the company’s green credentials.

Successful collaboration between FlexBio and the Edinburgh Genome Foundry demonstrates potential impact for future projects.

The success of this project provides opportunities for Scottish Water and Scottish Water Horizons to circularise a process for disposing of Human sewage sludge and cleaning wastewater of phosphorus. The project will contribute to Scottish Water’s commitment to Net Zero by 2040.

The technology developed in this successful Innovation Fund project could enable Ingenza to identify additional commercial opportunities to expand their current P. pastoris biologics manufacturing platform and attract new commercial end-user partnerships.

This successful project has moved SV alginate anodes for use in Lithium-ion batteries from proof of concept to late TRL 4 . MBL now hope to deliver commercial solution to market within the next three to five years. 

This project assessed the effect of growth media formulation and time of harvest on the growth rate, biochemical composition, and digestibility of a selection of phytoplankton maintained at CCAP, and identified two strains of commercial interest.

in this project co-funded with the High Value Biorenewables Network, the team successfully developed a process to extract alkaloids from daffodil biomass which could be used in the treatment of heart failure and are now in a position to apply for investment to take the process forward at scale in Scotland.

In this successful Feasibility Project, the project partners identified antiviral therapeutics that can be extracted from cyanobacteria, and gained leverage for additional funding, training opportunities, and developed new methods for fractionating and purifying polysaccharides.

Innovation funding enabled the academic team on this project to optimise their bacteria growing process and gave BAM Ritchies an insight into new opportunities, with the project collaborators set to continue to work together beyond the project.

This Feasibliity project by Artisan Roast, University of St Andrews, and Energy Recovery Systems Ltd demonstrated that coffee grounds are a profitable replacement for wood as a source for bioenergy.

Proof of concept was achieved in this Feasibility project to improve the strength and water repellent properties of Cellucomp’s paper-based packaging materials.

Innovation funding from IBioIC enabled the project partners to test a new strategy to elucidate the natural production mechanisms used by Taxus brevifolia, also known as the Pacific Yew, and engineer them in faster growing plant cells, and propelled Green Bioactives technology readiness level from 3 to 7.

In this successful project, Green Bioactives were able to access equipment which enabled them to detect their desired products and they can now further develop their cell lines and apply for funding to develop this aspect of the business.

Dr Stuart Hannah was able to undertake training through the RSE EF which helped him take the business from spinout proposition to fully-fledged incorporated company supported by early stage funding from private VCs

The Antibody Company (TAC) has expertise in point of care diagnostics for the aquaculture and brewing industries, which both suffer significant product losses. Current diagnostics for these industries are prohibitively expensive and take too long allow immediate mitigation. TAC combined their expertise in antibody design and production with Dr. Mulheran and his team’s skills in antibody conjugation to design a cheap and effective lateral flow device (LFD).

In this project funded by our Spin Out support programme, XGenix developed a high throughput assay to rapidly screen enzymes.

In this Feasibility project, CuanTec Limited and James Hutton Institute teamed up to analyse the value of side streams from crustacea shells.